Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pathway channels

Identifying Pathway Channels in Networks Extreme Pathway Analysis... [Pg.404]

We have traced the metabolic pathways channelling metabolites towards the fluorometabolites in S. cattleya and an overview of these relationships is shown in Figure 13. We believe that the substrate for the fluorination process is either a C3 phosphorylated glycolytic intermediate such as dihydroxyacetone phosphate or glyceraldehyde-3-phosphate, or alternatively a C2 metabolite such glycoaldehyde phosphate, derived from these compounds. Fluoroacetaldehyde appears to be a strong candidate for the role of common intermediate to both fluoroacetate and 4-fluorothreonine. [Pg.222]

Figure C2.12.7. Channel system of MFI (top) and MEL (bottom). The linear channels are interconnected by zigzag channels in ZSM-5 while exclusively straight miming channels are present in ZSM-11 - larger internal openings are present at the chaimel intersections - the arrows indicate the pathways for molecular transport tlirough the channel system. Figure C2.12.7. Channel system of MFI (top) and MEL (bottom). The linear channels are interconnected by zigzag channels in ZSM-5 while exclusively straight miming channels are present in ZSM-11 - larger internal openings are present at the chaimel intersections - the arrows indicate the pathways for molecular transport tlirough the channel system.
Many of the species involved in the endogenous metabolism can undergo a multitude of transformations, have many reaction channels open, and by the same token, can be produced in many reactions. In other words, biochemical pathways represent a multi-dimensional space that has to be explored with novel techniques to appreciate and elucidate the full scope of this dynamic reaction system. [Pg.564]

Phosphodiesterase Inhibitors. Because of the complexity of the biochemical processes involved in cardiac muscle contraction, investigators have looked at these pathways for other means of dmg intervention for CHF. One of the areas of investigation involves increased cycHc adenosine monophosphate [60-92-4] (cAMP) through inhibition of phosphodiesterase [9025-82-5] (PDE). This class of compounds includes amrinone, considered beneficial for CHF because of positive inotropic and vasodilator activity. The mechanism of inotropic action involves the inhibition of PDE, which in turn inhibits the intracellular hydrolysis of cAMP (130). In cascade fashion, cAMP-catalyzed phosphorylation of sarcolemmal calcium-channels follows, activating the calcium pump (131). A series of synthetic moieties including the bipyridines, amrinone and milrinone, piroximone and enoximone, [77671-31-9], C22H22N2O2S, all of which have been shown to improve cardiac contractiUty in short-term studies, were developed (132,133). These dmgs... [Pg.129]

Calcium Channel Blockers. Because accumulation of calcium is one of the facets of the mote involved process leading to atherosclerosis, it would foUow that the antihypertensive calcium channel blockers might be effective in preventing atheroma. Both verapamil (Table 1) and nifedipine (Table 3) have been shown to stimulate the low density Upoprotein (LDL) receptor (159). This specific receptor-mediated pathway could theoretically improve Upid metaboUsm in the arterial wall, and thereby prove antiatherogenic. These effects have been proven in animals. [Pg.131]

Fructose-6-phosphate generated in this way enters the glycolytic pathway directly in step 3, the second priming reaction. This is the principal means for channeling fructose into glycolysis in adipose tissue, which contains high levels of fructose. [Pg.634]

Natural product synthesis poses the challenge to consider and develop new pathways of structural transformation. Natural products as targets for synthetic research possess a special fertility in this regard, because the structural channels of biosynthesis are not necessarily the conduits of organic synthesis. A. Eschenmoser19... [Pg.9]

Bartter s syndrome is caused by mutations in the basolateral chloride channel (CIC-Kb), an exit pathway for cellular Cl. [Pg.249]


See other pages where Pathway channels is mentioned: [Pg.531]    [Pg.216]    [Pg.8]    [Pg.552]    [Pg.24]    [Pg.26]    [Pg.531]    [Pg.216]    [Pg.8]    [Pg.552]    [Pg.24]    [Pg.26]    [Pg.48]    [Pg.200]    [Pg.281]    [Pg.282]    [Pg.409]    [Pg.359]    [Pg.327]    [Pg.19]    [Pg.3]    [Pg.209]    [Pg.5]    [Pg.489]    [Pg.336]    [Pg.768]    [Pg.141]    [Pg.2]    [Pg.23]    [Pg.81]    [Pg.612]    [Pg.445]    [Pg.3]    [Pg.44]    [Pg.46]    [Pg.48]    [Pg.117]    [Pg.118]    [Pg.249]    [Pg.295]    [Pg.296]    [Pg.297]    [Pg.322]    [Pg.387]    [Pg.400]    [Pg.402]   
See also in sourсe #XX -- [ Pg.404 ]




SEARCH



© 2024 chempedia.info